ArticleBMC primary care2025
Understanding the patients' experience in Primary Technology Enhanced Care Home HbA1c Testing (PTEC HAT) programme-a qualitative study.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundType 2 Diabetes Mellitus (T2DM) related healthcare expenditure is expected to rise drastically as the incidence of diabetes associated comorbidities increases. It is vital to maintain an optimum glycaemia for patients with diabetes to reduce the risk of diabetes complications. Given the strong predictive value for diabetes complications, HbA1c remains the gold standard to monitor glycaemic control in contemporary clinical practice. The Primary Technology Enhanced Care (PTEC) Home HbA1c Testing (HAT) Programme is a telehealth programme that is intended to empower low-risk patients to test their HbA1c independently at home, supported with tele-monitoring and review through teleconsultation, saving them up to three clinic visits per year. Given the programme's reliance on active patient involvement, understanding patient experiences within the programme to identify the enablers and barriers of using various PTEC HAT components is important for guiding iterative improvement and informing scale-up strategies.
methodsA qualitative study approach was used to explore the in-depth perceptions of the patients who were enrolled into the pilot PTEC HAT programme. The non-adoption, abandonment, scale-up, spread, and sustainability (NASSS) framework was used to guide the development of topic guide and the analysis. The emergent results were categorised into the enablers and barriers.
resultsCoaching by healthcare team and access to supporting materials enabled the patients to complete the programme. The proactive reminder for home HbA1c testing by the in-app chatbot, the flexibility to perform the test round the clock, instant result review and the convenience of teleconsultation following home HbA1c test saved time and reduced clinic visits. Patient characteristic which enabled successful participation included a reasonable level of digital literacy, prior experience with health monitoring, absence of needle-related distress and strong intrinsic motivation. HbA1c reagent storage, syncing results via Bluetooth device, the prolonged onboarding process and the time gap between onboarding and first home-based testing were found to be challenging.
conclusionPTEC HAT programme was seen as a good alternative to routine clinic care for T2DM. Refinement in the on-boarding process and better support between onboarding and home-based independent testing could improve patient experience and satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.